SCHEMBL8618917

SCHEMBL8618917

COc1ccc(-c2cc(C(=O)NC(=N)N)c3ccccc3n2)c(OC)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.71
KDM4E B2RXH2 5/20 0.71
MEN1 O00255 4/20 0.71
POLB P06746 2/20 0.71
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
CA9 Q16790 1/20 0.65
TDP1 Q9NUW8 1/20 0.64
LMNA P02545 4/20 0.58
HPGD P15428 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
NPSR1 Q6W5P4 1/20 0.58
MAPT P10636 5/20 0.56
GAA P10253 1/20 0.56
ALDH1A1 P00352 2/20 0.56
HSP90AA1 P07900 1/20 0.54
THRB P10828 1/20 0.53
TP53 P04637 3/20 0.52
RXFP1 Q9HBX9 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8618677 0.92 CYP2D6 (0.60) KMT2AKDM4EMEN1POLBCA12
SCHEMBL8617742 0.89 TACR3 (0.63) KMT2AKDM4EMEN1POLBCA12
SCHEMBL8620708 0.85 MEN1 (0.68) KMT2AKDM4EMEN1POLBTDP1
SCHEMBL8619189 0.84 TACR3 (0.54) KMT2AKDM4EMEN1POLBLMNA
SCHEMBL8614851 0.83 MEN1 (0.67) KMT2AKDM4EMEN1TDP1LMNA
SCHEMBL8615674 0.83 CYP3A4 (0.58) KMT2AKDM4EMEN1TDP1LMNA
SCHEMBL8619351 0.83 DHODH (0.52) KMT2AKDM4EMEN1POLBCA12
SCHEMBL8616493 0.82 TACR3 (0.71) KMT2AKDM4EMEN1CA12CA1
SCHEMBL8614842 0.82 DHODH (0.72) KMT2AKDM4EMEN1POLBCA12
SCHEMBL8616670 0.82 CA9 (0.65) KMT2AKDM4EMEN1POLBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed